BEGIN:VCALENDAR VERSION:2.0 PRODID:-// - ECPv4.7.3//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://www.mdtechcouncil.com/membership/events X-WR-CALDESC:Events for BEGIN:VEVENT DTSTART;VALUE=DATE:20221014 DTEND;VALUE=DATE:20221116 DTSTAMP:20260504T201413 CREATED:20211209T165251Z LAST-MODIFIED:20220105T212200Z UID:2467-1665705600-1668556799@www.mdtechcouncil.com SUMMARY:2022 Maryland STEM Festival DESCRIPTION:The Festival will take place from October 14\, 2022 through November 15th.  The theme will be Cybersecurity and Information Technology.  Looking forward to this year’s festival\, anticipating hundreds of additional in-person events\, while maintaining the virtual access we’ve enjoyed over the obstacles two years! Keep checking our website and social media for more information on the 2022 Festival. \n URL:https://www.mdtechcouncil.com/membership/events/calendar/2022-maryland-stem-festival/ ORGANIZER;CN="Maryland%20STEM%20Festival":MAILTO:mdstemfest@gmail.com END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20221115T110000 DTEND;TZID=America/New_York:20221115T120000 DTSTAMP:20260504T201413 CREATED:20221102T191752Z LAST-MODIFIED:20221102T191752Z UID:3344-1668510000-1668513600@www.mdtechcouncil.com SUMMARY:NCI Tech Opportunity Webinar: "New Gene Therapy Method for Treating CRX-autosomal Dominant Leber Congenital Amaurosis (LCA)" DESCRIPTION:We invite you to register and join us on November 15 from 11:00 am – 12:00 pm ET for a free NCI technology webinar. Attendees will hear from Drs. Anand Swaroop\, Ph.D. and Kamil Kruczek\, Ph.D. of the National Eye Institute about a new gene therapy method for treating CRX-autosomal dominant Leber Congenital Amaurosis (LCA). LCA is a rare genetic disease that is responsible for about 20% of all childhood blindness. It’s caused by mutations in any of at least 25 genes that control photoreceptor development or function.  LCA has both recessive and dominant forms. Currently\, there is an FDA approved gene therapy for treating only one of the recessive forms of LCA caused by mutations in the RPE65 gene. In addition to most recessive forms\, the dominant form of LCA with underlying mutations in CRX remains untreatable. \nDr. Swaroop and his team developed a NEW gene therapy treatment for a dominant form of LCA that counteracts dominant mutations in the CRX gene.  More specifically\, correct CRX gene sequence packaged in an AAV vector was tested in retinal organoids derived from affected patients\, resulting in partial recovery of proper photoreceptor development. Importantly\, even partial recovery of photoreceptors should help patients regain useful vision.  This new technology shows promise as a viable treatment for a currently untreatable rare disease condition. \n URL:https://www.mdtechcouncil.com/membership/events/calendar/nci-tech-opportunity-webinar-new-gene-therapy-method-for-treating-crx-autosomal-dominant-leber-congenital-amaurosis-lca/ LOCATION:Virtual. Register at https://cbiit.webex.com/webappng/sites/cbiit/meeting/register/25ed644f1e9a4a6e85a03003e3208d97?ticket=4832534b00000005900d6ce32a2178551828097e8aa2a99f0ebb9b96e0dd535e6a5540cb465ef0d6×tamp=1667252989242&RGID=r8b181000ab92ec78192a8c031ab6d54d END:VEVENT END:VCALENDAR